Gossamer Bio, Inc. (GOSS)Healthcare | Biotechnology | San Diego, United States | NasdaqGS
0.42 USD
-0.03
(-5.830%) ⇩
(April 20, 2026, 4 p.m.
EDT)
Short-term: ★★☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:18 a.m. EDT
Despite narratives of a 'bottom' and strong revenue growth, founder notes below on Gossamer Bio (GOSS) are uninvestable today. The fundamental data reveals a capital-destroying operational business in distress: negative EPS, negative operating margins, negative free cash flow, and a book value of -0.52. The company is drowning in debt (202M) exceeding its cash (136M), creating a precarious liquidity situation. While the price has dropped 85% recently, aligning with a Phase 3 setback, there is no cushion left; another catalyst failure will likely trigger technical bankruptcy rather than a bounce. The lack of dividend and negative sales metrics confirm this is an avoid trap, not a value opportunity. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 1.338154 |
| AutoARIMA | 1.349826 |
| AutoETS | 1.352348 |
| MSTL | 1.377443 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 32% |
| H-stat | 8.11 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.019 |
| Excess Kurtosis | -1.15 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.212 |
| Market Cap | 98,572,440 |
| Forward P/E | -2.51 |
| Beta | 2.16 |
| Website | https://www.gossamerbio.com |
As of April 19, 2026, 12:18 a.m. EDT: Options flow indicates a distinct lack of naked call volume at strikes above the current price (0.446), with zero reported open interest for ITM puts at 45-day and 2-month expirations. However, there is a concentrated 'unger' (insurance) position where significant Call OI and Put OI pile up at strikes 3.0 and 7.0 for 2026-2028 expirations, suggesting an activist or bullish positioning thesis. Conversely, significant In-the-Money Put volume at strikes 0.5 and 1.5 for expirations under 6 months suggests active hedge buying or bearish hedging by long positions, while ATM call IV remains low (4.5%) indicating low immediate volatility expectations among speculators.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.4921403 |
| Address1 | 3,115 Merryfield Row |
| Address2 | Suite 120 |
| All Time High | 27.15 |
| All Time Low | 0.32 |
| Ask | 0.5447 |
| Ask Size | 2 |
| Audit Risk | 5 |
| Average Daily Volume10 Day | 7,141,960 |
| Average Daily Volume3 Month | 16,412,181 |
| Average Volume | 16,412,181 |
| Average Volume10Days | 7,141,960 |
| Beta | 2.159 |
| Bid | 0.318 |
| Bid Size | 2 |
| Board Risk | 8 |
| Book Value | -0.525 |
| City | San Diego |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.42 |
| Current Ratio | 2.643 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.46 |
| Day Low | 0.4143 |
| Display Name | Gossamer Bio |
| Earnings Call Timestamp End | 1,747,341,000 |
| Earnings Call Timestamp Start | 1,747,341,000 |
| Earnings Timestamp | 1,773,777,600 |
| Earnings Timestamp End | 1,778,788,800 |
| Earnings Timestamp Start | 1,778,788,800 |
| Ebitda | -163,228,992 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.008 |
| Enterprise To Revenue | 3.395 |
| Enterprise Value | 164,546,432 |
| Eps Current Year | -0.489 |
| Eps Forward | -0.167 |
| Eps Trailing Twelve Months | -0.75 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.784 |
| Fifty Day Average Change | -0.364 |
| Fifty Day Average Change Percent | -0.46428573 |
| Fifty Two Week Change Percent | -49.214027 |
| Fifty Two Week High | 3.87 |
| Fifty Two Week High Change | -3.4499998 |
| Fifty Two Week High Change Percent | -0.8914728 |
| Fifty Two Week Low | 0.32 |
| Fifty Two Week Low Change | 0.099999994 |
| Fifty Two Week Low Change Percent | 0.3125 |
| Fifty Two Week Range | 0.32 - 3.87 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,549,636,200,000 |
| Float Shares | 211,156,244 |
| Forward Eps | -0.167 |
| Forward P E | -2.51497 |
| Free Cashflow | -93,332,248 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 161 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 1.0 |
| Gross Profits | 48,471,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0416 |
| Held Percent Institutions | 0.72890997 |
| Implied Shares Outstanding | 234,696,281 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California. |
| Long Name | Gossamer Bio, Inc. |
| Market | us_market |
| Market Cap | 98,572,440 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_548541911 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -170,370,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 98,572,438 |
| Number Of Analyst Opinions | 7 |
| Open | 0.4391 |
| Operating Cashflow | -171,266,000 |
| Operating Margins | -3.3364701 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Phone | 858 684 1300 |
| Pre Market Change | -0.007999986 |
| Pre Market Change Percent | -1.9047587 |
| Pre Market Price | 0.412 |
| Pre Market Time | 1,776,776,675 |
| Previous Close | 0.446 |
| Price Eps Current Year | -0.8588957 |
| Price Hint | 4 |
| Price To Book | -0.8 |
| Price To Sales Trailing12 Months | 2.0336375 |
| Profit Margins | 0.0 |
| Quick Ratio | 2.356 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.026 |
| Regular Market Change Percent | -5.8296 |
| Regular Market Day High | 0.46 |
| Regular Market Day Low | 0.4143 |
| Regular Market Day Range | 0.4143 - 0.46 |
| Regular Market Open | 0.4391 |
| Regular Market Previous Close | 0.446 |
| Regular Market Price | 0.42 |
| Regular Market Time | 1,776,715,201 |
| Regular Market Volume | 4,480,509 |
| Return On Assets | -0.41856 |
| Revenue Growth | 0.471 |
| Revenue Per Share | 0.212 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 234,696,281 |
| Shares Percent Shares Out | 0.1598 |
| Shares Short | 37,500,300 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 34,715,538 |
| Short Name | Gossamer Bio, Inc. |
| Short Percent Of Float | 0.1697 |
| Short Ratio | 2.74 |
| Source Interval | 15 |
| State | CA |
| Symbol | GOSS |
| Target High Price | 15.0 |
| Target Low Price | 0.3 |
| Target Mean Price | 3.68571 |
| Target Median Price | 1.0 |
| Total Cash | 136,932,000 |
| Total Cash Per Share | 0.583 |
| Total Debt | 202,906,000 |
| Total Revenue | 48,471,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.75 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.111075 |
| Two Hundred Day Average Change | -1.691075 |
| Two Hundred Day Average Change Percent | -0.80104923 |
| Type Disp | Equity |
| Volume | 4,480,509 |
| Website | https://www.gossamerbio.com |
| Zip | 92,121 |